HomeFile

File

View Category
Acute coronary syndromes

TAVR: Should Transradial Approach be the Second Access Site?

Courtesy of Dr. Carlos Fava. One of the major challenges we interventional cardiologists still face is access management....
solaci -
Learn More
Antiplatelet

Alternatives for Patients Allergic to Aspirin

Intolerance to aspirin is relatively frequent and there is no other non-steroid anti-inflammatory medication to replace it. The...
solaci -
Learn More
Chronic Ischemic cardiopathy

Chronic Coronary Syndromes Nowadays

Multiple drugs and treatment strategies have emerged in recent years to change significantly the prognosis of patients...
solaci -
Learn More
Other

Is There a “Safe” Dose for Meat Consumption?

Meat consumption is associated with a small but significant increase in cardiovascular disease and all-cause mortality. The...
solaci -
Learn More
Coronary disease

Onyx ONE: More Options for Patients at High Risk for Bleeding

Since November 2015, when the LEADERS FREE was published in NEJM, polymer-free drug coated stents had undoubtedly...
solaci -
Learn More
Aorta

New European Guidelines on the Management of Lower Limb Acute Ischemia

Clinical practice guidelines are usually tedious and, frankly, while a lot of people make an enormous effort...
solaci -
Learn More
Coronary disease

Repeat Revascularization Is Not Benign, at Least in Left Main Disease

After the “EXCEL scandal” at the end of last year, study investigators have been publishing explanations and...
solaci -
Learn More
Femoropopliteal

Felling Reassured with Paclitaxel Coated Devices in Peripheral Artery Disease

This big analysis shows rapid absorption of paclitaxel coated devices for PCI in femoropopliteal territory, which reassures...
solaci -
Learn More